DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Epigral Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 3 hrs ago·22 Jul 2026, 7:49 am

Epigral

Epigral Limited has announced it will hold a conference call on Monday, July 27, 2026, to discuss its first-quarter results for fiscal year 2027. The company will use this platform to provide an overview of its financial performance and operational progress during the period.

This update is significant for investors as it offers a chance to hear management's commentary directly. Observers will be looking for insights into the company's execution strategy and how it is navigating the current market environment. The discussion is expected to provide clarity on future growth prospects and operational challenges.

Investors should pay close attention to the management's guidance and any questions raised during the interactive session. This information will be crucial for assessing the company's trajectory and making informed investment decisions.